IRIS
CONTE, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 693
NA - Nord America 314
EU - Europa 249
AF - Africa 79
SA - Sud America 79
OC - Oceania 1
Totale 1.415
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 374
US - Stati Uniti d'America 288
HK - Hong Kong 155
RU - Federazione Russa 82
BJ - Benin 59
BR - Brasile 56
IT - Italia 50
CN - Cina 49
VN - Vietnam 40
KR - Corea 38
DE - Germania 35
AT - Austria 22
CA - Canada 19
ZA - Sudafrica 14
AR - Argentina 12
PL - Polonia 12
UA - Ucraina 12
FI - Finlandia 10
GB - Regno Unito 8
BD - Bangladesh 7
IN - India 7
JP - Giappone 6
ES - Italia 5
EC - Ecuador 4
NL - Olanda 4
JM - Giamaica 3
MX - Messico 3
SE - Svezia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
ID - Indonesia 2
IL - Israele 2
IQ - Iraq 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
FR - Francia 1
GM - Gambi 1
MW - Malawi 1
NP - Nepal 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 1.415
Salva come PNG Salva come JPEG
Città #
Hong Kong 155
Singapore 146
Ashburn 62
Cotonou 59
Seoul 38
Los Angeles 32
Beijing 29
Buffalo 25
Moscow 25
Assago 20
Ho Chi Minh City 17
Nuremberg 12
New York 11
Helsinki 10
Vienna 10
Munich 9
Redondo Beach 9
Hanoi 8
Johannesburg 8
Warsaw 8
Dallas 7
São Paulo 6
Boston 5
Brembate di Sopra 5
Chennai 5
Milan 5
Montreal 5
Novara 5
Tokyo 5
Toronto 5
Atlanta 4
Chicago 4
Brooklyn 3
Da Nang 3
Denver 3
Falkenstein 3
Kingston 3
Ottawa 3
Poplar 3
San Francisco 3
Santa Clara 3
Stockholm 3
Amsterdam 2
Asunción 2
Baie-D'Urfé 2
Bishkek 2
Buenos Aires 2
Caracas 2
Carapicuíba 2
Curitiba 2
Frankfurt am Main 2
Guarulhos 2
Haiphong 2
Houston 2
Hải Dương 2
Katowice 2
Manchester 2
Marcos Paz 2
Matino 2
Mumbai 2
Nairobi 2
Parauapebas 2
Phoenix 2
Phủ Lý 2
Quito 2
Rio de Janeiro 2
Sarno 2
Secaucus 2
Venice 2
Americana 1
Ananindeua 1
Andradas 1
Baghdad 1
Barcelona 1
Bariloche 1
Barra Bonita 1
Barra da Estiva 1
Barras 1
Bauru 1
Belo Horizonte 1
Benito Juarez 1
Bismarck 1
Boca Toma 1
Boulder 1
Calgary 1
Candeias 1
Canoinhas 1
Cape Town 1
Cariacica 1
Changsha 1
Charlotte 1
Cleveland 1
Cosmópolis 1
Cotia 1
Dhaka 1
Dias dávila 1
District Heights 1
Doboj 1
Duhok 1
Empoli 1
Totale 869
Salva come PNG Salva come JPEG
Nome #
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy 55
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 50
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence 49
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 49
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial 48
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 48
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 46
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer 44
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer 43
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis 42
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 40
Frequency and spectrum of PIK3CA somatic mutations in breast cancer 39
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy 39
Update on the management of breast cancer during pregnancy 38
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 38
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients 38
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer 36
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 35
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis 35
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy 34
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 32
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients 32
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report. 32
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate 32
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 31
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies 30
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 29
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 28
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 27
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 27
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 26
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 26
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 24
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 24
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer 23
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 23
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 23
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 22
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis 22
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 20
Luteinizing hormone-releasing hormone analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor-positive breast cancer 20
Management of young women with early breast cancer 20
Management of young women with early breast cancer 19
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer 17
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 14
null 6
null 5
null 4
null 4
null 2
Totale 1.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025733 0 0 0 87 28 90 63 62 171 82 25 125
2025/2026757 108 73 151 126 284 15 0 0 0 0 0 0
Totale 1.490